Commentary
Podcast
Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO
Author(s):
On this episode of Managed Care Cast, we're talking with the chief medical officer of CVS Health about recent pharmaceutical innovations, patient-provider relationships, and strategies to reduce drug costs.
On this episode of Managed Care Cast, we're talking with Sreekanth Chaguturu, MD, the chief medical officer of CVS Health.
We discuss the impact of recent pharmaceutical innovations, namely glucagon-like peptide-1 (GLP-1) receptor agonists and biosimilars, on patient health outcomes. Also, we explore the role of trust between patients and providers in adopting new medications, along with initiatives used to reduce drug prices and improve access.
Listen above or on one of these podcast services:
Combatting the Opioid Epidemic: Insights From the Front Lines
